These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 3159488

  • 1. Cross resistance of quinolone derivatives in gram-negative bacteria.
    Barba D, Pennucci C, Esposito S, Galante D.
    Chemioterapia; 1985 Apr; 4(2):192-6. PubMed ID: 3159488
    [Abstract] [Full Text] [Related]

  • 2. Comparative in vitro activity of ciprofloxacin and five other quinoline derivatives against gram-negative isolates.
    Galante D, Pennucci C, Esposito S, Barba D.
    Drugs Exp Clin Res; 1985 Apr; 11(5):331-4. PubMed ID: 2941260
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Antibacterial in-vitro activity of pipemidic acid and nalidixic acid (author's transl)].
    Peters G, Freiesleben H, Marre R, Metz H, Tannenberg H, Pulverer G.
    Dtsch Med Wochenschr; 1979 Jun 29; 104(26):946-8. PubMed ID: 110574
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. In vitro activity of pefloxacin compared with five other quinolones on nalidixic acid-resistant proteae species.
    Piccolomini R, Cellini L, Allocati N, Di Girolamo A, Selan L, Scazzocchio F.
    Chemioterapia; 1988 Oct 29; 7(5):287-91. PubMed ID: 3224396
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Variations in vitro of the efficacy of quinolones as a function of pH].
    François B, Gille Y, Schmuck N, Assenat H, Adeleine P, Davoine P.
    Nephrologie; 1983 Oct 29; 4(6):259-62. PubMed ID: 6669186
    [Abstract] [Full Text] [Related]

  • 15. Comparative activities of ciprofloxacin (Bay o 9867), norfloxacin, pipemidic acid, and nalidixic acid.
    Muytjens HL, van der Ros-van de Repe J, van Veldhuizen G.
    Antimicrob Agents Chemother; 1983 Aug 29; 24(2):302-4. PubMed ID: 6227281
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [In vitro antibacterial activity of ciprofloxacin against uropathogenic organisms].
    Allocati N, Catamo G, Cellini L.
    Boll Soc Ital Biol Sper; 1984 Oct 30; 60(10):1927-33. PubMed ID: 6440583
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. In vitro activity of ciprofloxacin against aminoglycoside-sensitive and -resistant gram-negative rods.
    Speciale A, Blandino G, Pellegrino MB, Borghi P, Caccamo F.
    Chemioterapia; 1986 Jun 30; 5(3):196-9. PubMed ID: 2941174
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.